Propanc Biopharma (PPCB) Short Interest
Nasdaq • PPCB • US74346N8838
As of Oct 27, 2026, ORTEX estimated 9.2% of free float sold short, 0.1 days to cover, cost to borrow 129.27%. Sign up for live short interest data.
Nasdaq • PPCB • US74346N8838
As of Oct 27, 2026, ORTEX estimated 9.2% of free float sold short, 0.1 days to cover, cost to borrow 129.27%. Sign up for live short interest data.
This page tracks how heavily Propanc Biopharma (Nasdaq:PPCB) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Propanc Biopharma (Nasdaq: PPCB) has a market capitalization of $1.16M. Last close $1.84 (as of 2026-11-12); 52-week range $1.63 to $315.00. ORTEX data as of 2026-10-27: short interest was 9.22% of free float, 0.1 days to cover and the average cost to borrow was 129.27%. Sign up for live short interest data.